We are a specialized pharmaceutical company engaged in the production and sale of regenerative products including pharmaceuticals, medical devices, and cosmetics. Our core competency lies in the manufacturing technologies of PDRN (Polydeoxyribonucleotide) and PN (Polynucleotide), substances known to activate and enhance the body's natural regenerative mechanisms.

The R&D Center of PharmaResearch Co. is securing differentiated product competitiveness in the emerging regenerative medicine market that will be popularized in the near future, through continuous research and development on PDRN derived from Korean east coast returning salmon, and through manufacturing based on the DNA Optimization Technology (DOT™) patent.

Public

Pharma, CDMO, R&D Service, Bio